Hutch News

Hutch News

Stories tagged 'anogenital cancers'

Good News at Fred Hutch

Celebrating faculty and staff achievements

June 8, 2017

Fred Hutch epidemiologist Dr. Margaret Madeleine just received a five-year, $2.5 million grant from the National Cancer Institute to test whether the preventive HPV vaccine could be also be used as a therapy anogenital precancers.

View story >

HPV debate reframed to focus on cancer

U.S. cancer centers unanimously call for increase in vaccine use for cancer prevention

Jan. 27, 2016 | By Dr. Rachel Tompa / Fred Hutch News Service

All 69 National Cancer Institute-designated cancer centers are joining together to voice their frustration at the low uptake of the HPV vaccine — with the hope of refocusing the lens of the vaccination discussion on cancer prevention.

View story >

The HPV cancer vaccine: Are two doses as good as three?

A reduced dosing regimen may increase vaccination adherence, decrease costs

Aug. 26, 2014 | By Diane Mapes / Fred Hutch News Service

How do you get more people to take advantage of the cancer-busting HPV vaccine? One way might be to lower the number of doses, a hot topic among public health researchers attending HPV2014, the 29th International Papillomavirus Conference, which came to a close Monday in Seattle.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.